Joining a clinical trial starts with the informed consent process, where participants learn about the study’s purpose, procedures, and expectations. You’ll have the chance to ask questions and decide whether participation feels right for you.
In the EMBARQ Study, eligible adults with ColdU or symptomatic dermographism may receive an investigational injectable medication. Researchers will monitor participants closely and collect data to understand how the treatment works.
Participation is always voluntary, and you can withdraw at any time. Many people find comfort in knowing they are contributing to research that may help others living with chronic urticaria in the future.